Promotional product theaters provide time for presentation of new research findings on products, showcasing of product details, demonstrations and highlights of new products. These sessions are promotional and are not eligible for continuing education credits. Attendance at the product theaters is first-come, first-served and seating is limited. A refreshment break or meal is provided at each event.
Roger W. Sommi, Pharm.D., FCCP, BCPP
Professor of Pharmacy Practice and Psychiatry
UMKC Schools of Pharmacy and Medicine
Rahn K. Bailey, MD, FAPA
Elam Mental Health Center
Program Description: The emerging neuroscience discoveries are at odds with current, descriptive diagnostic conceptualization of MDD. Underlying contemporary syndromal definition of MDD, is an assumption that all depressed patients have similar neurobiological underpinning. Therefore diagnosis of MDD does not provide any precise therapeutic guidance. Algorithmic treatment approaches put all the depressed patients through the same treatment sequence, with suboptimal outcome. Genetic, neuroimaging and biochemical studies of MDD point to a significant pathophysiological diversity within the same diagnostic category. If we assume that most effective treatments accurately interface with the most relevant underling pathophysiological processes, would it not make sense to first identify these processes? Attempts to guide personalized treatment by identifying pertinent disease markers will be discussed.
Vladimir Maletic, MD, MS
Clinical Professor of Neuropsychiatry and Behavioral Science
University of South Carolina School of Medicine in Columbia
Consulting Associate in the Division of Child and Adolescent Psychiatry, Department of Psychiatry
Durham, North Carolina